HIV associated nephropathy cost-effectiveness of therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
The [[World Health Organization|World Health Organization (WHO)]] data on HIV/AIDS for 2018 is 37.9 million people living with HIV/AIDS worldwide and 770 000 deaths due to HIV-related illnesses worldwide.<ref name="urlWHO | HIV/AIDS" /> | The [[World Health Organization|World Health Organization (WHO)]] data on HIV/AIDS for 2018 is 37.9 million people living with HIV/AIDS worldwide and 770 000 deaths due to HIV-related illnesses worldwide.<ref name="urlWHO | HIV/AIDS" /> There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy. | ||
==Cost-effectiveness of Therapy== | ==Cost-effectiveness of Therapy== | ||
*There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy. | |||
The [[World Health Organization|World Health Organization (WHO)]] data on HIV/AIDS is as the following for 2018:<ref name="urlWHO | HIV/AIDS">{{cite web |url=https://www.who.int/gho/hiv/en/ |title=WHO | HIV/AIDS |format= |work= |accessdate=}}</ref> | *The [[World Health Organization|World Health Organization (WHO)]] data on HIV/AIDS is as the following for 2018:<ref name="urlWHO | HIV/AIDS">{{cite web |url=https://www.who.int/gho/hiv/en/ |title=WHO | HIV/AIDS |format= |work= |accessdate=}}</ref> | ||
*People living with HIV/AIDS: 37.9 million people living with HIV/AIDS worldwide in 2018 | **People living with HIV/AIDS: 37.9 million people living with HIV/AIDS worldwide in 2018 | ||
*Mortality: 770,000 people died of HIV-related illnesses worldwide in 2018 | **Mortality: 770,000 people died of HIV-related illnesses worldwide in 2018 | ||
==References== | ==References== | ||
Latest revision as of 07:47, 5 July 2020
|
HIV associated nephropathy Microchapters |
|
Differentiating HIV associated nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
HIV associated nephropathy cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of HIV associated nephropathy cost-effectiveness of therapy |
|
FDA on HIV associated nephropathy cost-effectiveness of therapy |
|
CDC on HIV associated nephropathy cost-effectiveness of therapy |
|
HIV associated nephropathy cost-effectiveness of therapy in the news |
|
Blogs on HIV associated nephropathy cost-effectiveness of therapy |
|
Risk calculators and risk factors for HIV associated nephropathy cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
The World Health Organization (WHO) data on HIV/AIDS for 2018 is 37.9 million people living with HIV/AIDS worldwide and 770 000 deaths due to HIV-related illnesses worldwide.[1] There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy.
Cost-effectiveness of Therapy
- There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy.
- The World Health Organization (WHO) data on HIV/AIDS is as the following for 2018:[1]
- People living with HIV/AIDS: 37.9 million people living with HIV/AIDS worldwide in 2018
- Mortality: 770,000 people died of HIV-related illnesses worldwide in 2018